Myfembree
My Prescription
Payment
Select pharmacy
$1,283.75
Print or send this coupon to your phone
AlbertsonsPowered byAbout Myfembree
Drug Details
Myfembree is a medication combining relugolix, estradiol, and norethindrone, specifically designed for women who have not yet reached menopause. It is primarily used to manage heavy menstrual bleeding caused by uterine fibroids and to alleviate moderate-to-severe pain associated with endometriosis. This oral tablet is taken once daily. Relugolix functions by reducing the production of certain hormones, which in turn decreases the levels of female sex hormones, leading to symptom relief. Estradiol helps to prevent bone loss that can result from relugolix use, while norethindrone works to lower the risk of uterine cancer linked to estradiol. Common side effects may include hot flashes and headaches. Always consult with a healthcare professional before starting any new medication to ensure it is appropriate for your condition.
Price history for Myfembree
28 Tablets, 40-1-0.5MG
Average retail price for Myfembree
Average SaveHealth price for Myfembree
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Myfembree dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 40-1-0.5MG | 28 Tablets | $1,283.95 | $45.86 |
Myfembree FAQs
Myfembree has been shown to be effective in clinical trials for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Patients have reported a significant reduction in menstrual blood loss. However, individual responses to the medication can vary, and it is important for patients to discuss with their healthcare provider to determine if it is the right treatment option for their specific condition.
Myfembree is a medication that combines relugolix, estradiol, and norethindrone acetate. It is used to manage heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Relugolix works by reducing the production of certain hormones, leading to decreased estrogen levels, which helps shrink fibroids and reduce bleeding. Estradiol and norethindrone acetate are added to help mitigate the side effects of low estrogen, such as bone loss.
Myfembree is not specifically indicated for weight loss. While some individuals may experience changes in weight as a side effect, it is not a common or intended effect of the medication. If there are concerns about weight changes while taking Myfembree, it is advisable to consult with a healthcare provider.
Yes, Myfembree is a medication that can help reduce the size of uterine fibroids. It works by altering hormone levels, which can lead to a decrease in fibroid size and associated symptoms. However, individual responses to the medication can vary, and it is important for patients to discuss treatment options with their healthcare provider.
When starting Myfembree, a patient can expect some common side effects such as hot flashes, headaches, fatigue, and mood changes. It is also possible to experience changes in menstrual bleeding patterns, including lighter periods or no periods at all. Some individuals may experience weight gain or changes in bone density over time. It is important for the patient to follow up with their healthcare provider regularly to monitor their response to the medication and manage any side effects.